Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px
Document › Details

Bruker Corporation. (11/22/16). "Press Release: Bruker Completes Acquisition of Preclinical PET Imaging Business". Billerica, MA.

Organisations Organisation Bruker Corporation (Nasdaq: BRKR)
  Group Bruker Corporation (Group)
  Organisation 2 Oncovision
Products Product Albira™ Si PET/SPECT/CT system
  Product 2 positron emission tomography (PET)
Index term Index term Oncovision–Bruker Corp: investment, 201609 acquisition €na of preclinical imaging business of Oncovision by Bruker
Persons Person Jung, Wulf I. (Bruker 201009 Managing Director of Bruker BioSpin GmbH)
  Person 2 Laukien, Frank H. (Bruker 201204 President + CEO)
     


Key molecular imaging technology positions Bruker for growth in preclinical PET/MRI and PET/SPECT/CT


Bruker today announced that it has completed the acquisition of the preclinical PET imaging business of Oncovision, a leading provider of innovative medical imaging devices. Bruker had previously announced an agreement to acquire this business in September 2016. Financial terms were not disclosed.

The recently introduced, next-generation AlbiraSi™ preclinical PET/SPECT/CT system features advanced silicon photomultiplier (SiPM) technology. This proprietary detector technology allows the highest full field-of-view PET resolution and sensitivity, a major advantage over traditional PET technology. This innovation has also allowed the development of the first SiPM-based PET insert for preclinical MRI systems, giving researchers the benefit of simultaneous PET and MRI measurements.

Dr. Wulf I. Jung, President of Bruker's Preclinical Imaging Division, stated: "PET imaging is one of the most important imaging modalities for translational research. With this acquisition Bruker is strengthening its leadership in preclinical imaging. The unique, performance-leading SiPM PET detector technology, and other PET capabilities developed in close collaboration with the molecular imaging institute I3M and the University of Valencia, offer outstanding spatial resolution across the full field of view (FOV), increasing the high-resolution FOV by an order of magnitude compared to traditional PET systems, and thereby facilitating quantitative imaging investigations."

Frank H. Laukien, Ph.D., President and CEO of Bruker Corporation, commented: "Bruker continues to invest and position itself for sustainable growth in the important preclinical imaging market. We are very pleased with this advanced technology acquisition, and believe that our unique PET/MRI and PET/SPECT/CT systems will significantly advance quantitative, highest resolution PET translational research."


About Bruker Corporation (NASDAQ: BRKR)

For more than 50 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific research instruments and high-value analytical solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.

In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy, nano-analysis and industrial applications, as well as in cell biology, preclinical imaging, clinical research, microbiology and molecular diagnostics. For more information: www.bruker.com/preclinicalimaging


Investor contact:

Miroslava Minkova
Head of Investor Relations
Bruker Corporation
T: +1 (978) 663-3660, ext. 1479
E: Miroslava.Minkova@bruker.com


Media contact:

Dr. Thorsten Thiel
Head of Group Marketing
Bruker BioSpin Group
T: +49 (0)721–5161, ext. 6500
E: thorsten.thiel@bruker.com

   
Record changed: 2017-01-17

Advertisement

Picture EBD Group Cell & Gene Exchange 2017 Washington DC USA May 600x60px

More documents for Bruker Corporation (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group Cell & Gene Exchange 2017 Washington DC USA May 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Cell & Gene Exchange 2017 Washington DC USA May 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px